Healthcare / Health Information ServicesKOSDAQ
$1946.00
-52.00 (-2.60%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 33% · confianza 23%
FCF escenarios
weak_data · normalized FCF $-12.5B · quality 69.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
38/100
D
Piotroski
6/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$37.8B
P/E
2.0x
↓EV/EBITDA
0.0x
↓ROE
28.0%
↑Gross Margin
98.1%
↑Debt/Equity
0.05
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
-2.3%
FCF CAGR
—
FCF margin
-18.7%
FCF / Net income
-0.80x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $81.69B · net income $19.18B · FCF $-15.30B
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $81.69B | $81.69B | $83.19B | $81.83B | $87.61B |
| Net Income | $19.18B | $19.18B | $-20.28B | $-24.47B | $-26.12B |
| EBITDA | $27.74B | $27.74B | $-12.37B | $-14.23B | $-20.25B |
| EPS | 989.00 | 989.00 | -1045.00 | -1289.00 | -1455.00 |
| Gross Margin | 98.1% | 98.1% | 98.7% | 97.4% | 96.6% |
| Operating Margin | -3.5% | -3.5% | -5.4% | -14.2% | -7.0% |
| Net Margin | 23.5% | 23.5% | -24.4% | -29.9% | -29.8% |
| Balance Sheet | |||||
| Debt/Equity | 0.05 | 0.05 | 1.00 | 0.78 | 0.68 |
| Current Ratio | 2.70 | 2.70 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-15.30B | $-15.30B | $-4.38B | $-12.54B | $-10.34B |
| Returns | |||||
| ROE | 28.0% | 28.0% | -41.9% | -35.7% | -30.9% |
| Valuation | |||||
| P/E | 1.97 | 1.97 | — | — | — |
| EV/EBITDA | 0.05 | 0.05 | — | — | — |
| P/B | 0.55 | 0.55 | 1.05 | 1.22 | 1.41 |
| Growth & Yield | |||||
| Revenue Growth | -1.8% | -1.8% | 1.7% | -6.6% | — |
| EPS Growth | 194.6% | 194.6% | 18.9% | 11.4% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
-44.1%
EPS terminal req.
$172.68
Spread vs growth
238.7%
5Y implied EPS CAGR
-26.7%
EPS terminal req.
$208.94
Spread vs growth
221.4%
10Y implied EPS CAGR
-10.2%
EPS terminal req.
$336.49
Spread vs growth
204.9%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-37.1%
Start / end P/E
n/dx → n/dx
EPS bridge
-1045.00 → 989.00
Residual
-37.1%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.